The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019. The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market. The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103721.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/chinese-orthopedic-biomaterials-market-market-report.html.
No comments:
Post a Comment